Zydus Receives Final Approval From The USFDA For Zinc Sulfate Injection

Zydus Receives Final Approval From The USFDA For Zinc Sulfate Injection

Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.

FPJ Web DeskUpdated: Thursday, August 24, 2023, 11:29 AM IST
article-image
Zydus Receives Final Approval From The USFDA For Zinc Sulfate Injection | Image: Zydus (Representative)

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as Zydus) has received final approval from the United States Food and Drug Administration (USFDA) for Zinc Sulfate Injection USP, 10 mg/10 mL (1 mg/mL), 30 mg/10 mL (3 mg/mL), and 25 mg/5 mL (5 mg/mL) Pharmacy Bulk Package Vials, the company on Thursday announced through an exchange filing.

Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. The drug will be manufactured at the group’s formulation manufacturing facility at Jarod.

Zinc Sulfate Injection USP, 10 mg/10 mL (1 mg/mL), 30 mg/10 mL (3 mg/mL), and 25 mg/5 mL (5 mg/mL) Pharmacy Bulk Package Vials had annual sales of USD 17.1 million in the United States.

The group now has 377 approvals and has so far filed over 444 (as of 31st June 2023) ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Lifesciences Limited shares

The shares of Zydus Lifesciences on Thursday at 11:25 am IST were at Rs 648.75, up by 0.53 percent.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Paytm Allots 27,687 Shares To Employees As Stock Option

Paytm Allots 27,687 Shares To Employees As Stock Option

Marksans Pharma Announces US FDA Approval For Esomeprazole Magnesium Delayed-Release Capsules

Marksans Pharma Announces US FDA Approval For Esomeprazole Magnesium Delayed-Release Capsules

DGCA Proposes Barring Pilots And Crew From Using Perfume

DGCA Proposes Barring Pilots And Crew From Using Perfume

NCC Secures Orders Worth ₹4,205.94 Cr In September 2023 Across Diverse Divisions

NCC Secures Orders Worth ₹4,205.94 Cr In September 2023 Across Diverse Divisions

Escorts Kubota Construction Equipment Volume Grows By 51.8% In September

Escorts Kubota Construction Equipment Volume Grows By 51.8% In September